Two schedules of etirinotecan pegol (NKTR-102) in patients with previously treated metastatic breast cancer: a randomised phase 2 study. [electronic resource]
Producer: 20131227Description: 1216-25 p. digitalISSN:- 1474-5488
- Adult
- Aged
- Aged, 80 and over
- Breast Neoplasms -- drug therapy
- Camptothecin -- administration & dosage
- Drug Administration Schedule
- Europe
- Female
- Heterocyclic Compounds, 4 or More Rings -- administration & dosage
- Humans
- Intention to Treat Analysis
- Irinotecan
- Kaplan-Meier Estimate
- Middle Aged
- Polyethylene Glycols -- administration & dosage
- Time Factors
- Topoisomerase I Inhibitors -- administration & dosage
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.